𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Additive effects of hyperbaric oxygen and platelet-derived growth factor-BB in chondrocyte transplantation via up-regulation expression of platelet-derived growth factor-β receptor

✍ Scribed by Li-Jen Yuan; Chi-Chien Niu; Song-Shu Lin; Yi-Sheng Chan; Chuen-Yung Yang; Wen-Jer Chen; Steve W.N. Ueng


Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
334 KB
Volume
27
Category
Article
ISSN
0736-0266

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The present study investigated the effects of hyperbaric oxygen (HBO) and platelet‐derived growth factor‐BB (PDGF‐BB) in chondrocyte transplantation. In vitro, chondrocytes were treated with HBO, PDGF‐BB, and HBO combined with PDGF‐BB (H+P). Cell growth was analyzed using cell counting, MTT assay, and FACS analysis. mRNA expression of the PDGF‐α receptor (PDGFR‐α) and β receptor (PDGFR‐β) was detected by RT‐PCR. Protein expression of PDGFR‐β was detected by Western blotting. In vivo, chondrocytes and PDGF‐BB were suspended in alginate as a transplantation system. Cartilage defects were grafted with this system and with or without HBO treatment. Released PDGF‐BB concentration was quantified by ELISA. After 8 weeks, animals were sacrificed and the repaired tissues were examined. In vitro data suggested that each treatment increased cell growth via the up‐regulated mRNA expression of PDGFR‐α and increased cell accumulation in the S‐phase. The H+P treatment was more additive in cell growth and in mRNA and protein expression of PDGFR‐β than HBO or PDGF‐BB. In vivo results suggested that PDGF‐BB delivery lasted for more than 5 weeks. Scoring results showed that each treatment significantly increased the cartilage repair. Safranin‐O and type II collagen staining confirmed the hyaline‐like cartilage regeneration in the repaired tissues. In situ up‐regulation of PDGFR‐β expression partially explains the additive effect of H+P treatment in cartilage repair. Accordingly, H+P offers a potential treatment method for cartilage repair. © 2009 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 27:1439–1446, 2009


📜 SIMILAR VOLUMES


Effects of low density lipoprotein recep
✍ Lihua Wu; Sanja Arandjelovic; Steven L. Gonias 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB

## Abstract The low density lipoprotein receptor related protein‐1 (LRP‐1) is a cargo transport receptor that undergoes constitutive endocytosis and recycling. Platelet‐derived growth factor‐BB (PDGF‐BB) binds to LRP‐1 and may bridge LRP‐1 to PDGF receptors. Bridging of LRP‐1 to other receptors by

Expression of c-ABL, c-KIT, and platelet
✍ Rosemarie E. Schmandt; Russell Broaddus; Karen H. Lu; Hyun Shvartsman; Angela Th 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

## Abstract ## BACKGROUND Tyrosine kinases, such as c‐KIT, c‐ABL, and platelet‐derived growth factor‐beta (PDGFR‐β), are important regulators of cell growth. Highly potent and selective inhibitors of tyrosine kinases are being investigated as alternatives to standard chemotherapy. One such inhibit

Different inhibitory effect of imatinib
✍ Akiko Ohashi; Kazuo Kinoshita; Koji Isozaki; Toshirou Nishida; Yasuhisa Shinomur 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 195 KB 👁 1 views

## Abstract Most gastrointestinal stromal tumors (GISTs) have gain‐of‐function mutations of the c‐__kit__ gene. Previously, we found 2 types of gain‐of‐function mutation of the __PDGFRA__ gene, Val^561^ to Asp and Asp^842^ to Val, in about half of GISTs without c‐__kit__ gene mutations. Although th